Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
Plos One
|
January 15, 2010
A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials
John Simes, Merryn Voysey, Rachel O'Connell, et al.
European Journal of Preventive Cardiology
|
July 23, 2021
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, et al.
Circulation. Cardiovascular Interventions
|
August 10, 2012
The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention
Martin K C Ng, Andy S C Yong, Michael Ho, et al.
Atherosclerosis
|
January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Dan Atar, J Wouter Jukema, Bart Molemans, et al.
Resuscitation
|
January 31, 2026
ECPR eligible refractory out of hospital cardiac arrests - a post-hoc analysis of the EVIDENCE Randomised Controlled Trial and Registry
Miles Greenberg, Brian Burns, Patrick Lay, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Marc S Sabatine, Robert P Giugliano, Anthony Keech, et al.
JACC. Cardiovascular Interventions
|
November 10, 2021
Novel Pressure-Regulated Deployment Strategy for Improving the Safety and Efficacy of Balloon-Expandable Transcatheter Aortic Valves
Afik Snir, Michael K Wilson, Lining A Ju, et al.
Clinical Chemistry
|
April 26, 2008
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment
Gilles Lambert, Nicolas Ancellin, Francesca Charlton, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
Runguo Wu, Claire Williams, Junwen Zhou, et al.
Plos One
|
January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy
, Jonathan R Emberson, Patricia M Kearney, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
Plos One
|
January 15, 2010
A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials
John Simes, Merryn Voysey, Rachel O'Connell, et al.
European Journal of Preventive Cardiology
|
July 23, 2021
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, et al.
Circulation. Cardiovascular Interventions
|
August 10, 2012
The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention
Martin K C Ng, Andy S C Yong, Michael Ho, et al.
Atherosclerosis
|
January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Dan Atar, J Wouter Jukema, Bart Molemans, et al.
Resuscitation
|
January 31, 2026
ECPR eligible refractory out of hospital cardiac arrests - a post-hoc analysis of the EVIDENCE Randomised Controlled Trial and Registry
Miles Greenberg, Brian Burns, Patrick Lay, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Marc S Sabatine, Robert P Giugliano, Anthony Keech, et al.
JACC. Cardiovascular Interventions
|
November 10, 2021
Novel Pressure-Regulated Deployment Strategy for Improving the Safety and Efficacy of Balloon-Expandable Transcatheter Aortic Valves
Afik Snir, Michael K Wilson, Lining A Ju, et al.
Clinical Chemistry
|
April 26, 2008
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment
Gilles Lambert, Nicolas Ancellin, Francesca Charlton, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
Runguo Wu, Claire Williams, Junwen Zhou, et al.
Plos One
|
January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy
, Jonathan R Emberson, Patricia M Kearney, et al.
Page
of 10